miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway

Por Chen, Xuan-Ying, Huang, Wei-Lin, Peng, Xiao-Ping, Lv, Yan-Ni, Li, Jun-He, Xiong, Jian-Ping
Publicado no Toxicol Res (Camb) (2019)

An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases

Por Li, Fang, Lv, Yan-ni, Tan, Yi-sha, Shen, Kai, Zhai, Ke-feng, Chen, Hong-lin, Kou, Jun-ping, Yu, Bo-yang
Publicado no Acta Pharmacol Sin (2015)

The saponin D39 blocks dissociation of non‐muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis

Por Zhai, Ke‐feng, Zheng, Jin‐rong, Tang, You‐mei, Li, Fang, Lv, Yan‐ni, Zhang, Yuan‐yuan, Gao, Zhen, Qi, Jin, Yu, Bo‐yang, Kou, Jun‐ping
Publicado no Br J Pharmacol (2017)